The Global Times reporter Hu Yuwei (GT) recently talked exclusively to the German-based vaccine developer BioNTech's CEO, Ugur Sahin (Sahin) who expressed his strong confidence in the marketing prospects of the vaccine in China. The approval has entered the final ...
The European Medicines Agency (EMA) has started a rolling review of China's Sinovac COVID-19 vaccine, the EU's top drug regulator announced Tuesday, and experts said that once the vaccine is approved, China will further fulfill its international responsibilities as a ...
Mekong River countries' diplomats expressed that they value the scientific, regulatory effect of Chinese dams on water resources, following their latest in-person visits to the main hydropower stations along the Lancang River, recognizing China's role in bringing practical benefits to ...
China's potential approval of BioNTech's mRNA COVID-19 vaccine has entered the final stage in decision-making processes, and the conversation with Chinese authorities is very "encouraging," German-based vaccine developer BioNTech's CEO Ugur Şahin told the Global Times in an exclusive interview ...
Recipients can accept a second COVID-19 shot developed using the same technique but by a different producer under special conditions, a Chinese health official said on Thursday, vowing to increase supply to ensure success of the injection of the second ...
The Global Times recently visited Tianjin-based CanSinoBIO's third production plant as it rolled out the latest batch of COVID-19 vaccines. The 15,000-square-meter plant complies with the international Good Manufacture Practice of Medical Products (GMP) standards and has an automatic line ...
The Global Times reporters Hu Yuwei and Bai Yunyi (GT) recently interviewed the Brazilian Ambassador to China Paulo Estivallet de Mesquita (Estivallet) to review remarkable moments in their joint fight against the coronavirus.
CanSino Biologics (CanSinoBIO) is expected to increase the annual production capacity of its recombinant adenovirus vector COVID-19 vaccine - the only single-dose vaccine approved in China - to 200 to 300 million doses after its third plant comes into full ...
A Saturday commemoration of Ping-Pong Diplomacy was seen by observers as "more relevant" when China and the US have increasingly confrontational relations and "require flexible people-to-people exchanges" to retain positive exchanges and push forward cooperation, observers said.
As public trust in the Japanese government was shaken like the earthquake that hit Fukushima Nuclear Power Plant, China's top nuclear scientist joined the chorus of criticism to express deep disappointment over Japan's recent decision to dump nuclear-contaminated Fukushima wastewater ...
The COVID-19 mRNA vaccine co-developed by German-based BioNTech and China's Fosun Pharma can be rolled out in the Chinese mainland very quickly once it receives authorization, as key steps for mass production are close to ready, the Global Times learned ...
Fosun Pharm has submitted the clinical trial data of a COVID-19 mRNA vaccine it co-developed with German BioNTech and relevant materials to China's state regulator for rolling review, a source close to Fosun told the Global Times on Sunday. This ...
China's Sinovac COVID-19 vaccine has 50.7 percent efficacy and has proved to be effective against the variants known as P1 and P2 that are prevalent in Brazil, latest data showed. Moreover, the Sinovac vaccine's efficacy rate can climb to 62.3 ...
On the commemoration of the 50th anniversary of the ping-pong diplomacy, Chinese and US veteran table tennis players recalled the memories of the visit by US table tennis players to China in 1971 and looked back to how a bouncing ...
50 years after “ping-pong diplomacy”, Chinese player Zheng Minzhi and US player Dell and Connie Sweeris made a video call. The three old friends recall and share memories of the ice-breaking trips to each other's countries in the 1970s.
Gong Yunzun, Party chief of Ruili, Southwest China's Yunnan Province, has been dismissed from his post for serious negligence in epidemic control, where more than 100 local infections had been reported so far in the latest flare-up.
While some US political forces keep inciting hostility against China, and an inherited Sino-skepticism that has continually caused raising antagonism and discrimination against the Chinese, and by extension, other Asian communities, the Global Times found that there are many Americans ...
China issues Poverty Alleviation White Paper after declaring complete victory over poverty. It unveils what China and CPC can share in its innovative approaches and how it can cooperate with more countries in poverty alleviation.
China is running the world's largest nationwide campaign to encourage COVID-19 inoculation via creative, considerate, and non-coercive measures to persuade people to get vaccinated. Choices made by the public will be crucial in achieving the herd immunity goal of immunizing ...
The Indian health authority announced on Wednesday that a new "double mutant" variant of the COVID-19 has been found in the country, raising concerns over whether the unique variant would be more infectious and could reduce efficacy of existing COVDI-19 ...
China's leading vaccine producer CanSino Biologics obtained the national drug regulator's approval on Monday to start clinical trials of its latest recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) in inhalation form.
Shortly after European Union foreign ministers signed off on a slate of punitive measures on Monday over alleged human rights abuses, including sanctions directed at China, China hit back with tit-for-tat countermeasures by sanctioning 10 individuals and four entities that ...
As the Chinese Embassy in Myanmar urged measures to stop violence and punish the perpetrators who smashed, looted and burnt Chinese-funded factories in Yangon, some "NGOs," such as the Burma Human Rights Network (BHRN), acting in the name of human ...
As one of the leading COVID-19 vaccine manufacturers in China, Sinovac has expanded its annual production capacity to 2 billion doses and offered its inactivated vaccines to over 16 countries and regions. The Global Times reporters Hu Yuwei and Leng ...
On the seventh anniversary of the disappearance of Malaysia Airlines flight MH370 falling on Wednesday, relatives of the missing Chinese passengers are planning to set up a foundation to offer rewards for continuing the search.
Zhu Tao, a member of the 13th National Committee of the Chinese People's Political Consultative Conference, proposed accelerating China's mass vaccination program to inoculate 70 percent of the population and achieve herd immunity by the end of 2021.
China's pharmaceutical giant Sinopharm will expand COVID-19 vaccine production capacity to 3 billion doses per year, becoming the world's biggest vaccine producer for the virus, Chairman of Sinopharm Group Yu Qingming told the media.
It is extremely unlikely that the death of a Hong Kong resident who received the Sinovac COVID-19 vaccine is linked to the vaccine, and Hong Kong's vaccination program will not be affected as the incident was a mere coincidence, health ...
China is ramping up efforts to vaccinate 560 million people, or 40 percent of China's population, by the end of June, and another 330 million people will be vaccinated by the end of the year, covering 64 percent of the ...
While its own people in Texas are in dire straits amid an electricity-related crisis, the US has turned its attention to the Mekong water resource issue, while turning a blind eye to China's efforts to resolve the problems.
The virus vector used in the vaccine produced by Chinese company CanSinoBIO is safer for the human body and easier to produce, the company CEO said Sunday after China and the US both approved their single-shot recombinant adenovirus vector COVID-19 ...
The first batch of 685,000 doses of the COVID-19 mRNA vaccine co-developed by Germany's BioNTech and China's Fosun Pharma arrived in Hong Kong on Saturday, the Global Times learned.
China's COVID-19 protein subunit vaccines have reported encouraging progress as a leading Chinese vaccine producer, Sinopharm, plans to bring its newly developed recombinant subunit vaccine candidate into clinical trial.
On Chinese New Year's Eve, Gou Jinbo, who was spearheading the Chinese scientific team in Pakistan for the COVID-19 vaccine Phase III clinical trials, scoffed up a few dumplings and rushed back to the clinical trial site.
Pakistan became the first country to receive the third batch of Chinese COVID-19 vaccines, as it approved on Monday the final phase of clinical trials of the Chinese vaccines, co-developed by the Institute of Microbiology of the Chinese Academy of ...
Chinese experts and netizens called on the WHO to launch probe mission on the origins of virus in wider scale across the world, especially those with evidence of coronavirus found earlier than the outbreak in Wuhan, after the WHO said ...
The migrant workers who stay in Beijing due to #COVID19 control measures celebrated Spring Festival with a community gala in Pi Village, one of the largest urban villages. They made dumplings, sang songs and read poems with their children to ...
CanSino's COVID-19 single-dose vaccine reported overall 65.7% efficacy at preventing symptomatic cases and 90.98% against severe disease in Phase III trials interim result.
While many central and western European countries, who put all faith in Western-produced COVID-19 vaccines, continue to scramble for scarce doses, those left behind have urged "it is time to trust Chinese vaccines." As Turkey, Hungary, Bosnia and Serbia keep ...
China's drug regulator has given conditional approval for the mass use of COVID-19 vaccine produced by Chinese pharmaceutical firm Sinovac Biotech, China's second COVID-19 vaccine.
Chinese pharmaceutical company Fosun Pharma, a partner of German Biotech company BioNTech, is on track to seek approval from the Chinese regulator for the COVID-19 mRNA vaccine in the Chinese mainland, Dr. Aimin Hui, President of Global R&D and Chief ...
The development of COVID-19 mRNA vaccines may not have come so fast without the efforts of a scientist from China who has invested years in laying the groundwork.
Amid a white-hot global vaccine battle, where a row caused by the EU and the UK, and US pharmaceuticals over the delayed delivery continues to flare, another Chinese vaccine, developed by CanSino Biologics, which guarantees dual protection after only one ...
More than 80 people were arrested and 3,000 doses of fake COVID-19 vaccines were confiscated in a special campaign that China has carried out to crack down on vaccine-related crimes. The suspects had been profiting from the illegal manufacturing and ...
The AD5-nCOV vaccine candidate developed by Chinese biopharmaceutical company CanSino Biologics has met its pre-specified primary safety and efficacy criteria at interim analysis, with no serious adverse events, and the company will continue to advance its phase III clinical trial ...
Rich countries have been accused of “modern piracy” after reportedly using diverse tactics to source life-saving COVID-19 vaccines. Recent quarrels over scarce vaccines bring back memories of the wrestle for life-saving masks in the early stage of the outbreaks last ...
Given concerns that wealthy states are fueling a gap in COVID-19 vaccine access around the world, rich states, which are jostling for early jabs, are urged to share, not hoard, at the virtual Davos Agenda 2021 summit of global leaders ...
What are the approval criteria for COVID-19 vaccines in China? Are Chinese vaccines still effective against mutant strains? How to view compliment, doubt and smearing over the safety and efficacy of China's vaccines?
Chinese drug authorities had obtained the final-stage data of Chinese-developed inactivated vaccines as early as late October, ahead of most countries, Shao Yiming, a leading expert advising on China's vaccine research and development, who participated in vaccine data analysis and ...
Chinese inactivated vaccines are effective for all coronavirus mutants spread to China from overseas in recent outbreaks, according to lab tests conducted by Chinese scientists, Shao Yiming, a leading expert advising on China's vaccine research and development, told the Global ...
Chinese inactivated vaccines are effective for all coronavirus mutants spread to China from overseas in recent outbreaks, according to lab tests conducted by Chinese scientists, Shao Yiming, a leading expert advising on China's vaccine research and development, told the Global ...
After a coronavirus strain in Beijing's recent cases was reportedly found to be the same as a variant in the UK, public concern arose over the effectiveness of Chinese vaccines, especially after scientists found that new variants in the UK, ...
While surrogacy services continued throughout the pandemic, the virus did bring about risks and even tragedy. Media reported that some babies born to surrogate mothers have been left stranded overseas due to lockdown measures.
Brazil has begun its COVID-19 vaccine rollout on Sunday with doses developed by Chinese producer Sinovac, soon after the regulatory approval for its emergency use, bringing relief amid a surge in cases.
Indonesian Ambassador to China Djauhari Oratmangun (Oratmangun) pinned hopes on Chinese-developed COVID-19 vaccines in a latest exclusive interview with the Global Times reporter Hu Yuwei (GT).
A video of Serbian President Aleksandar Vucic welcoming the arrival of the COVID-19 vaccines in the cold wind went viral on Chinese social media platforms over the weekend, touching millions of Chinese netizens who applauded Vucic's strong endorsement of Chinese ...
Brazil's health regulator Anvisa on Thursday urged AstraZeneca and Sinovac-Butantan to submit further documentation required for their COVID-19 vaccines' getting emergency use approval on Sunday.
Indonesian Ambassador to China Djauhari Oratmangun cast hopes on Chinese-developed COVID-19 vaccines on controlling the pandemic in Indonesia in an exclusive interview with the Global Times on Thursday, and applauded Chinese State Councilor and Foreign Minister Wang Yi's pledge for ...
More countries announced they would purchase China's COVID-19 vaccines or start mass inoculations using them, as senior officials of various countries stressed the safety of the Chinese vaccines despite some Western media questioning their efficacy and safety.
China's CoronaVac COVID-19 vaccine produced by Sinovac has been proven safe and effective after phase III trials conducted in several countries, boosting public confidence over its global rollout as Indonesian President Joko Widodo received his first shot of the CoronaVac ...
Sinovac's COVID-19 vaccine is 100 percent effective in preventing severe and moderate infections, 77.96 percent effective in preventing mild cases, and has an overall efficacy of 50.4 percent in Brazil's final-stage trials.
Chinese State Councilor and Foreign Minister Wang Yi on Tuesday started his visit to Indonesia as part of his four-nation tour of Southeast Asia, which comes after Indonesia announced on Monday an emergency approval of a Chinese-developed COVID-19 vaccine in ...
China has likely vaccinated more than 10 million doses in mass inoculation efforts for first high-risk groups so far, experts estimated, as health departments ramped up the national immunization plan, racing against infection resurgences in a number of provinces including ...
Chinese expert Tao Lina stressed that Chinese inactivated vaccines are safe and said VOA twisted his words to mean the opposite in its news article.
India expects to export its homemade coronavirus vaccines "within weeks" to satisfy the global market, according to media reports, which experts said could be a good news given India's competitive vaccine research and production capacity.
More Chinese cities have begun mass COVID-19 vaccinations after the New Year holidays as China has approved its domestically produced vaccine for general use and expanded its scope of vaccination during the winter and spring seasons with the country soon ...
With China's first domestically produced COVID-19 vaccine getting conditional approval for general use, local health systems throughout China have unveiled public vaccination campaigns starting with the high-risk groups, aiming to administer shots to millions of people before the travel rush ...
The largest COVID-19 vaccination site in Beijing's Chaoyang district entered the fourth day of its operation on Monday. It vaccinated more than 2,000 people on Monday, who were taken in groups to the site in minibuses.
China's capital city Beijing, along with East China's Shandong Province, has started its first round of free mass COVID-19 vaccinations for key groups amid sporadic cases. Beijing has set up 220 vaccination sites where more than 70,000 people have received ...
Chinese vaccine producers Sinopharm and Sinovac have denied selling unapproved vaccines overseas, after Japanese media accused China of seeking to expand its influence through smuggled vaccines, the Global Times learned from sources. Chinese experts slammed such allegations as coming "out ...
A Chinese vaccine expert predicted that China is likely to realize herd immunity by the end of 2021 after up to 1 billion Chinese residents, or 70 percent of Chinese people, are vaccinated.
China on Thursday officially issued approval for conditional mass use of the first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.
As the COVID-19 pandemic rages across the world, vaccines have become a life-saving straw that many people are eager to grasp. But at the moment, the availability is limited and the first batches are earmarked for those in the most ...
The United Arab Emirates has become the world's first country to offer Chinese-developed COVID-19 vaccines to all citizens and residents for free as part of its efforts to achieve nationwide immunity against the coronavirus.
China approved the country's leading vaccine producer Sinopharm's application for market rollout of its COVID-19 vaccines on Thursday, which marks China's first approval for a vaccine to combat the coronavirus.
Sinovac Biotech Ltd may further optimize its vaccines in late-stage clinical trials and release efficacy data along with results obtained from Indonesia and Turkey in 15 days to meet the increasing international demand for its vaccines, Chinese experts said on ...
As European countries have ramped up their lockdown measures amid a resurgence of COVID-19 cases and the US broke the global record for daily new infections on Friday with more than 400,000 cases, China is moving on with vaccine research ...
As the world holds high hopes for a vaccine to emerge amid the pandemic, global biological and drug firms are racing on research and development (R&D) efforts and rolling out their products as early as possible, and the participation of ...
China is calculating how many people working in high-risk professions, including cold-chain, medical and port workers, will need to receive COVID-19 vaccines, health officials said Monday.
Chinese COVID-19 vaccines do not strive to be the first or the best, but that vaccine research and development should demonstrate a respect for science, health officials said Monday in response to concerns over China's vaccine R&D lagging behind in ...
China is calculating how many people working in high-risk professions will need to receive COVID-19 vaccines, health officials said Monday, as the travel rush of the Chinese New Year, also known as the world's largest annual human migration, draws close. ...
China's leading vaccine maker Sinovac is working around the clock to prepare for mass production, with the first production line to secure 300 million doses of a COVID-19 vaccine annually, the Global Times learned after an exclusive visit to the ...
The Global Times reporters on Sunday visited the COVID-19 vaccine Beijing manufacturing plant of leading Chinese vaccine producer Sinovac to see how vaccines go through a complex packaging process - from vaccine bulk grouting to packaging - before they are ...
Chinese vaccines are gaining momentum as more countries order China-produced COVID-19 vaccines, with Brazil being the latest to put China's Sinovac Biotech vaccines into its national immunization plan.
China is preparing for mass production of COVID-19 vaccine, said national health authority on Wednesday.
Tangyuan county in Northeast China's Heilongjiang Province on Tuesday opened registration for the public to sign up for two doses of the COVID-19 vaccines for 420 yuan ($60) in total, becoming the first region in China to officially open early ...
China has seen a nationwide logistics rehearsal to prepare for the upcoming COVID-19 vaccine mass use, as some leading vaccine producers have been conducting large-scale transport drills across the country since Friday.
Chinese-developed inactivated COVID-19 vaccine has 86 percent efficacy against the virus, the United Arab Emirates (UAE) health ministry said on Wednesday, based on their interim analysis of phase three clinical trials.
China's diplomatic style is increasingly more assertive and confident as it faces up against stigmatization and provocative behaviors from the West, even becoming more significantly active in condemning Western nations over blatant violations of human rights worldwide, but now the ...
As global vaccine providers speed up trials and various countries scramble to set up distribution, December has become a flashpoint for the global vaccine race as COVID-19 vaccine candidates approach the end of late-stage testing.
Brazil on Thursday received 600 liters of Chinese-produced COVID-19 inactivated vaccine concentrate, for S?o Paulo's plan to inject its state citizens in a mass vaccination in January. The vaccine will assist Brazil in its battle against the COVID-19 pandemic, which ...
As more countries, including the UK, Japan and Russia, are eager to roll out massive vaccination programs to combat the deadly coronavirus, China stressed a scientific and diversified pathway to mass vaccination that can satisfy global criteria.
Amid an escalating war of words around a cartoon depicting atrocities committed by Australian soldiers against Afghan civilians, an Australian who has lived in China for 10 years has something to say: "Today, as an Australian, I feel ashamed. The ...
Chinese vice premier Sun Chunlan stressed a scientific and rigorous preparation is required for the mass production of Chinese-developed COVID-19 vaccines during an inspection tour of vaccine production lines of some leading manufacturers in Beijing on Wednesday, the same day ...
African and some Latin American countries would prefer Chinese-developed inactivated vaccines, due to their competitive costs and easier logistics, to stop their pandemic crisis, said analysts in both the vaccine and drug transportation services.
China made good on its promise to share year-round hydrological data on upper reaches of the Mekong River with the kickoff of an online information sharing platform on Monday. The platform aims to provide reliable forecasting and early warning services ...
China has always taken a responsible attitude towards the development and utilization of cross-border rivers, and adopts a policy that protection goes together with development, China's Embassy to India said in relation to China's Yarlung Zangbo River hydropower project ...
Diplomats from countries in the Association of Southeast Asian Nations (ASEAN) and representatives have acclaimed China's COVID-19 vaccines, expressing their confidence in promising results and expectations for further cooperation. The praise contrasts sharply with some Western media claims that Southeast ...
With Chinese President Xi Jinping crediting China-ASEAN relationship as "the most successful and vibrant model for cooperation" in the Asia-Pacific, the bilateral relations between the two economies will navigate toward a diamond decade after 10 years of "golden era" - ...
Southeast Asian countries envision greater involvement in China's development and look forward to working with the Communist Party of China (CPC) to promote regional multilateralism, said representatives to a dialogue between the CPC and political parties of Southeast Asian countries ...
November has witnessed an information explosion of global COVID-19 research and development. In the 16 days from November 9 to 25, three Western vaccine producers - Pfizer, Moderna and AstraZeneca - have revealed their interim Phase-III clinical trial data, and ...
China's leading vaccine producer Sinopharm announced Wednesday that it has submitted an application to Chinese authorities for marketization of its COVID-19 vaccine.
China said it will prioritize the strengthening of international cooperation on vaccine development, and make concrete efforts to promote equal distribution, as the Chinese leader has promised to make the vaccines accessible to developing countries on major diplomatic occasions, including ...
Shanghai Pudong Airport started on Sunday night testing all staff after the airport found several cargo handlers and close contacts tested positive for the coronavirus over the past several days.
Chinese vaccine makers said that China's full-throttled development of COVID-19 vaccines remains in the lead among a roster of effective vaccines, although some Western media and politicians have questioned China for delays in releasing late-stage trial data after US drug ...
Brazil's sudden suspension of Chinese COVID-19 vaccine trials on November 9 raised concerns about obstacles China faces in exporting its vaccines. Although clinical trials of the vaccine soon resumed in Brazil, political wrangling behind multi-layered stakeholders and commercial interests in ...
The most cutting-edge Chinese self-produced unmanned helicopters were recently equipped to People's Liberation Army (PLA) Tibet Military Command troops at the border with India. The command had ordered smart weapons and customized equipment - from portable oxygen generators to a ...
Chinese-developed COVID19 vaccine CoronaVac has made progress in its late-stage clinical trials in Turkey as there have been 1,111vaccinations in 638 volunteers - all healthcare workers - across local 25 medical centers as of November 16, the trials study coordinator ...
The first batch of a COVID-19 vaccine candidate, developed by Beijing-based Sinovac Biotech (SINOVAC), has finally left for Sao Paulo, Brazil. This is believed to be a positive sign of the two sides' agreement on SINOVAC providing the South ...
With Joe Biden being declared the winner of the US presidential election, many have discussed what changes his administration might bring to China-US relations. Policymakers and analysts around the world are speculating what policies and tools Biden will use to ...
Biden's win marks a more transparent, predictable and disciplined way of dealing with China as opposed to the shotgun approach to threaten or address bilateral concerns, said US economist Stephen Roach, a senior fellow at Yale University's Jackson Institute for ...
China is willing to provide the necessary convenience for a Brazilian delegation to inspect the research and development of China's COVID-19 vaccines, in accordance with relevant laws and international practices, the Chinese Foreign Ministry said Friday, as Brazil plans to ...
Brazilian authorities may resume the trials of a Chinese coronavirus vaccine in two to three days after a review process, a source close to the matter told the Global Times, as the reported "severe adverse" case was said to be ...
The death of a volunteer participating in tests of the Chinese-produced Coronavac vaccine was caused by suicide, local media reported, quoting a local police report on Tuesday.
Nepali Congress, a political party in Nepal widely tagged as a pro-India force, was considered the main institution behind the rumors.
The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazil's health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is not related to the vaccine itself, after foreign media said the ...
US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while Sinopharm's inactivated vaccine showed 100 percent efficacy at one case in Mexico, both are promising results and have brought about hope of wider use ...
The Chinese Foreign Ministry said Tuesday that Brazil's health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is not related to the vaccine itself, after foreign media said the suspension is due to a "severe adverse ...
Fabricated Western media reports accusing China of encroaching on Nepalese bordering lands reflect the political intentions of some anti-China forces and pro-Indian activists, said some Nepalese observers who shared their first-hand observations and analysis with the Global Times.
Since the Belt and Road Initiative (BRI) was proposed in 2013, China has invested and constructed more than 80 hydropower projects globally across six continents. While helping different regions raise standards of living and stimulate their economies, these projects also ...
